본문 바로가기
KERD
논문KCI 등재

Efficacy of luteal estrogen administration and an early follicular Gonadotropin-releasing hormone antagonist priming protocol in poor responders undergoing in vitro fertilization

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류산부인과학

초록

Objective We investigated whether luteal estrogen administration and an early follicular Gonadotropin-releasing hormone antagonist (E/G-ant) priming protocol improves clinical outcomes in poor responders to controlled ovarian stimulation for in vitro fertilization (IVF)-embryo transfer, and identified underlying mechanisms. Methods This restrospective study consisted of 65 poor responders who underwent the E/G-ant priming protocol. Sixty-four other poor responders undergoing conventional protocols without pretreatment were included as the control group. Clinical outcomes were compared between 2 groups. Results The E/G-ant priming protocol group exhibited improvements over the control group in terms of the number of retrieved oocytes (3.58±2.24 vs. 1.70±1.45; P=0.000), mature oocytes (2.68±2.11 vs. 1.65±1.23; P=0.000), fertilized oocytes (2.25± 1.74 vs. 1.32±1.26; P=0.001), good embryos (1.62±0.91 vs. 1.14±0.90, P=0.021). Day 3 follicle-stimulating hormone (FSH; 8.40±4.84 vs. 16.39±13.56; P=0.000) and pre-ovulation progesterone levels (0.67 vs. 1.28 ng/mL; P=0.016) were significantly higher in the control group than in the E/G-ant priming group. The overall rate of positive human chorionic gonadotropin tests was higher in the E/G-ant priming group than in the control group (32.3% vs.16.1%; P=0.039). Also, clinical pregnancy rate (26.2% vs. 12.5%; P=0.048) and the rate of live births (23.1% vs. 7.1%; P=0.023) were significantly higher in the E/G-ant priming group than in the control group. Conclusion The E/G-ant priming protocol would lead to promising results in poor responders to IVF by suppressing endogenous FSH and by preventing premature luteinization.

Abstract

Objective We investigated whether luteal estrogen administration and an early follicular Gonadotropin-releasing hormone antagonist (E/G-ant) priming protocol improves clinical outcomes in poor responders to controlled ovarian stimulation for in vitro fertilization (IVF)-embryo transfer, and identified underlying mechanisms. Methods This restrospective study consisted of 65 poor responders who underwent the E/G-ant priming protocol. Sixty-four other poor responders undergoing conventional protocols without pretreatment were included as the control group. Clinical outcomes were compared between 2 groups. Results The E/G-ant priming protocol group exhibited improvements over the control group in terms of the number of retrieved oocytes (3.58±2.24 vs. 1.70±1.45; P=0.000), mature oocytes (2.68±2.11 vs. 1.65±1.23; P=0.000), fertilized oocytes (2.25± 1.74 vs. 1.32±1.26; P=0.001), good embryos (1.62±0.91 vs. 1.14±0.90, P=0.021). Day 3 follicle-stimulating hormone (FSH; 8.40±4.84 vs. 16.39±13.56; P=0.000) and pre-ovulation progesterone levels (0.67 vs. 1.28 ng/mL; P=0.016) were significantly higher in the control group than in the E/G-ant priming group. The overall rate of positive human chorionic gonadotropin tests was higher in the E/G-ant priming group than in the control group (32.3% vs.16.1%; P=0.039). Also, clinical pregnancy rate (26.2% vs. 12.5%; P=0.048) and the rate of live births (23.1% vs. 7.1%; P=0.023) were significantly higher in the E/G-ant priming group than in the control group. Conclusion The E/G-ant priming protocol would lead to promising results in poor responders to IVF by suppressing endogenous FSH and by preventing premature luteinization.

참고문헌 (56)

  1. Hendriks DJ, "Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level", Fertil Steril, 83, pp.291~301 (2005)[DOI]
  2. Pandian Z, "Interventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF)", Cochrane Database Syst Rev, pp.CD004379~ (2010)
  3. Cakmak H, "A novel "delayed start" protocol with gonadotropinreleasing hormone antagonist improves outcomes in poor responders", Fertil Steril, 101, pp.1308~1314 (2014)[DOI]
  4. Polyzos NP, "A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel", Fertil Steril, 96, pp.1058~1061 (2011)[DOI]
  5. Keay SD, "Assisted conception following poor ovarian response to gonadotrophin stimulation", Br J Obstet Gynaecol, 104, pp.521~527 (1997)[DOI]
  6. Surrey ES, "Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques", Fertil Steril, 73, pp.667~676 (2000)[DOI]
  7. Vollenhoven B, "Is there an ideal stimulation regimen for IVF for poor responders and does it change with age?", J Assist Reprod Genet, 25, pp.523~529 (2008)[DOI]
  8. Jenkins JM, "Comparison of 'poor' responders with 'good' responders using a standard buserelin", human menopausal gonadotrophin regime for in-vitro fertilization, 1991, pp.6, 918~921
  9. Cheung LP, "GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial", Hum Reprod, 20, pp.616~621 (2005)[DOI]
  10. Ubaldi F, "Management of poor responders in IVF: is there anything new?", BioMed Res Int, 2014, pp.352098~ (2014)
  11. Kyrou D, "How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis", Fertil Steril, 91, pp.749~766 (2009)[DOI]
  12. Kligman I, "Differentiating clinical profiles: predicting good responders, poor responders, and hyperresponders", Fertil Steril, 76, pp.1185~1190 (2001)[DOI]
  13. Saldeen P, "The probability of successful IVF outcome after poor ovarian response", Acta Obstet Gynecol Scand, 86, pp.457~461 (2007)[DOI]
  14. Rosen MP, "A quantitative assessment of follicle size on oocyte developmental competence", Fertil Steril, 90, pp.684~690 (2008)[DOI]
  15. Devreker F, "Selection of good embryos for transfer depends on embryo cohort size: implications for the 'mild ovarian stimulation' debate", Hum Reprod, 14, pp.3002~3008 (1999)[DOI]
  16. Opsahl MS, "The number of embryos available for transfer predicts successful pregnancy outcome in women over 39 years with normal ovarian hormonal reserve testing", J Assist Reprod Genet, 18, pp.551~556 (2001)[DOI]
  17. Fanchin R, "Coordination of early antral follicles by luteal estradiol administration provides a basis for alternative controlled ovarian hyperstimulation regimens", Fertil Steril, 79, pp.316~321 (2003)[DOI]
  18. Klein NA, "Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women", J Clin Endocrinol Metab, 81, pp.1038~1045 (1996)
  19. Chun SY, "Hormonal regulation of apoptosis in early antral follicles: follicle-stimulating hormone as a major survival factor", Endocrinology, 137, pp.1447~1456 (1996)[DOI]
  20. Dragisic KG, "Use of a luteal estradiol patch and a gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation for in vitro fertilization in poor responders", Fertil Steril, 84, pp.1023~1026 (2005)[DOI]
  21. Fanchin R, "Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists", Hum Reprod, 18, pp.2698~2703 (2003)[DOI]
  22. Van Soom A, "Assessment of mammalian embryo quality: what can we learn from embryo morphology?", Reprod Biomed Online, 7, pp.664~670 (2003)[DOI]
  23. Frattarelli JL, "A luteal estradiol protocol for expected poorresponders improves embryo number and quality", Fertil Steril, 89, pp.1118~1122 (2008)[DOI]
  24. Chang EM, "Effect of estrogen priming through luteal phase and stimulation phase in poor responders in in-vitro fertilization", J Assist Reprod Genet, 29, pp.225~230 (2012)[DOI]
  25. Copperman AB, "Antagonists in poor-responder patients", Fertil Steril, 80(Suppl 1), pp.S16~S24 (2003)
  26. Frankfurter D, "Novel follicular-phase gonadotropin-releasing hormone antagonist stimulation protocol for in vitro fertilization in the poor responder", Fertil Steril, 88, pp.1442~1445 (2007)[DOI]
  27. Younis JS, "Early and short follicular gonadotropin-releasing hormone antagonist supplementation improves the meiotic status and competence of retrieved oocytes in in vitro fertilization-embryo transfer cycles", Fertil Steril, 94, pp.1350~1355 (2010)[DOI]
  28. Blockeel C, "Optimisation of the follicular phase in IVF", ICSI, 2012, pp.4, 203~212
  29. Fanchin R, "Premature progesterone elevation spares blastulation but not pregnancy rates in in vitro fertilization with coculture", Fertil Steril, 68, pp.648~652 (1997)[DOI]
  30. Fanchin R, "Consequences of premature progesterone elevation on the outcome of in vitro fertilization: insights into a controversy", Fertil Steril, 68, pp.799~805 (1997)[DOI]
  31. Hugues JN, "Impact of 'LH activity' supplementation on serum progesterone levels during controlled ovarian stimulation: a systematic review", Hum Reprod, 27, pp.232~243 (2012)[DOI]
  32. Shulman A, "The significance of an early (premature) rise of plasma progesterone in in vitro fertilization cycles induced by a "long protocol" of gonadotropin releasing hormone analogue and human menopausal gonadotropins", J Assist Reprod Genet, 13, pp.207~211 (1996)[DOI]
  33. Lidor AL, "Management of women with polycystic ovary syndrome who experienced premature luteinization during clomiphene citrate treatment", Fertil Steril, 74, pp.749~752 (2000)[DOI]
  34. Younis JS, "Increased progesterone", estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropinreleasing hormone agonist, 2001, pp.76, 294~299
  35. Venetis CA, "Progesterone elevation and probability of pregnancy after IVF: facts and fiction", Hum Reprod Update, 14, pp.538~ (2008)[DOI]
  36. Xu B, "Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles", Fertil Steril, 97, pp.1321~1327 (2012)[DOI]
  37. Venetis CA, "Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles", Hum Reprod Update, 19, pp.433~457 (2013)[DOI]
  38. Ferraretti AP, "ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria", Hum Reprod, 26, pp.1616~1624 (2011)[DOI]
  39. Jansen R, "Towards reproductive certainty: fertility and genetics beyond 1999: the plenary", Proceedings of the 11th World Congress (1999)
  40. Garcia JE, "Human menopausal gonadotropin", human chorionic gonadotropin follicular maturation for oocyte aspiration: phase II, 1981, 1983, pp.39, 174~179
  41. Templeton A, "Factors that affect outcome of in-vitro fertilisation treatment", Lancet, 348, pp.1402~1406 (1996)[DOI]
  42. Ulug U, "Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles", Reprod Biomed Online, 6, pp.439~443 (2003)[DOI]
  43. Hendriks DJ, "Expected poor ovarian response in predicting cumulative pregnancy rates: a powerful tool", Reprod Biomed Online, 17, pp.727~736 (2008)[DOI]
  44. Gougeon A, "Evolution of the diameters of the largest healthy and atretic follicles during the human menstrual cycle", J Reprod Fertil, 69, pp.497~502 (1983)[DOI]
  45. Bosch E, "Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome", Fertil Steril, 80, pp.1444~1449 (2003)[DOI]
  46. Harada T, "Reduced implantation rate associated with a subtle rise in serum progesterone concentration during the follicular phase of cycles stimulated with a combination of a gonadotrophin-releasing hormone agonist and gonadotrophin", Hum Reprod, 10, pp.1060~1064 (1995)[DOI]
  47. Fanchin R, "Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer", Fertil Steril, 59, pp.1090~1094 (1993)[DOI]
  48. Hofmann GE, "Premature luteinization during controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer has no impact on pregnancy outcome", Fertil Steril, 66, pp.980~986 (1996)[DOI]
  49. Fanchin R, "Premature progesterone elevation does not alter oocyte quality in in vitro fertilization", Fertil Steril, 65, pp.1178~1183 (1996)[DOI]
  50. Saleh HA, "Does subtle progesterone rise on the day of HCG affect pregnancy rate in long agonist ICSI cycles?", J Assist Reprod Genet, 26, pp.239~242 (2009)[DOI]
  51. Requena A, "High progesterone levels in women with high ovarian response do not affect clinical outcomes: a retrospective cohort study", Reprod Biol Endocrinol, 12, pp.69~ (2014)[DOI]
  52. Kolibianakis EM, "Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists", Fertil Steril, 82, pp.102~107 (2004)
  53. Fleming R, "The source and implications of progesterone rise during the follicular phase of assisted reproduction cycles", Reprod Biomed Online, 21, pp.446~449 (2010)[DOI]
  54. Achache H, "Endometrial receptivity markers, the journey to successful embryo implantation", Hum Reprod Update, 12, pp.731~746 (2006)[DOI]
  55. Shufaro Y, "Progesterone-to-follicle index is better correlated with in vitro fertilization cycle outcome than blood progesterone level", Fertil Steril, 103, pp.669~674 (2015)[DOI]
  56. Oudendijk JF, "The poor responder in IVF: is the prognosis always poor?: a systematic review", Hum Reprod Update, 18, pp.1~11 (2012)[DOI]

관련 논문AI추천

The effect of aromatase inhibitor letrozole incorporated in gonadotrophin-releasing hormone antagonist multiple dose protocol in poor responders undergoing in vitro fertilization강병문, 권수경, 김성훈, 김정훈, 석혜진, 이경희, 이유정, 채희동대한산부인과학회 · Obstetrics & Gynecology Science2014 · 제57권 제03호The clinical outcomes of fresh versus frozen embryos transfer in women ≥40 years with poor ovarian responseConghui Liu, Hong Jiang, Xiaomin Song, Yingchun Liu, Yu Li대한산부인과학회 · Obstetrics & Gynecology Science2021 · 제64권 제3호ORAL CONTRACEPTIVE PILL PRETREATMENT IN OVARIAN STIMULATION WITH GnRH ANTAGONISTS FOR IN VITRO FERTILIZATION: A COMPARATIVE STUDY강인수, 궁미경, 김혜옥, 박찬우, 성나영, 송인옥, 양광문, 양승헌, 차선화, 추연실, 한애라대한산부인과학회 · Obstetrics & Gynecology Science2011 · 제54권 제10호Ovarian Features after 2 Weeks, 3 Weeks and 4 Weeks Transdermal Testosterone Gel Treatment and Their Associated Effect on IVF Outcomes in Poor Responders강병문, 김성훈, 김정훈, 문제원, 안준우, 채희동한국발생생물학회 · 발생과 생식2014 · 제18권 제3호Association between different dual trigger dosages and in vitro fertilization results in patients with patientoriented strategies encompassing individualized oocyte number group IV강민경, 김민경, 김지원, 김진영, 김태형, 유상우, 이우식, 장은미대한산부인과학회 · Obstetrics & Gynecology Science2022 · 제65권 제2호Clinical factors that affect the pregnancy rate in frozen-thawed embryo transfer in the freeze-all policy주종길, Eun Hye Jeon, Seo Yoon Hwang, Seung Chul Kim영남대학교 의과대학 · Journal of Yeungnam Medical Science2020 · 제37권 제1호

이 간행물의 다른 논문 (11건)